Pregnancy registry for narcolepsy or sleep apnea treatments
Part of Brain & nervous system, Lungs & breathing, Mental health clinical trials.
This study tracks the health of pregnant women who have narcolepsy or sleep apnea, or who have taken certain wake-promoting medications during pregnancy. It helps researchers learn more about the safety of these treatments for mothers and babies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant at any age.
- You have narcolepsy or obstructive sleep apnea, OR you have taken solriamfetol or other wake-promoting medications or stimulants during pregnancy or shortly before conception.
- You live in the United States or Canada.
- You agree to participate and allow your healthcare provider to share your medical information with the study team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects information about pregnancy outcomes in women who took WAKIX (pitolisant) or a similar comparison medicine during pregnancy. It helps doctors understand the safety and effects of these medicines in pregnancy.
This is a research registry that collects information from people with narcolepsy and other neurological sleep disorders. It may help doctors better understand sleep problems and improve future care.
This trial studies a “rescue” set of medicines for obstructive sleep apnea when two common treatments haven’t worked well enough. If you still have frequent breathing pauses during sleep, the study may test whether these medicines can reduce them and improve safety and symptoms.
This study looks at how narcolepsy or idiopathic hypersomnia affects thinking and cardiovascular health, and how usual treatment medications may change those outcomes. It may help researchers understand risks and benefits of common hypersomnia therapies.
This trial tests a new nerve-stimulation therapy called Neuromod to treat moderate-to-severe sleep apnea in people who do not have access to other treatments. If you qualify, you would be part of a study to see if this implant helps improve your breathing during sleep.
This study collects information in a registry to help doctors understand outcomes for young people with moderate-to-severe obstructive sleep apnea who cannot use CPAP and may use an implantable breathing stimulation device. You might qualify if you’ve tried and couldn’t tolerate CPAP and you’re able/willing to get and use the device and return for follow-ups and sleep tests.
Hear when a new Narcolepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.